UK markets open in 2 hours 59 minutes
NIKKEI 225
37,956.59 +328.11 (+0.87%) HANG SENG
17,592.97 +308.43 (+1.78%) CRUDE OIL
83.83 +0.26 (+0.31%) GOLD FUTURES
2,344.90 +2.40 (+0.10%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,504.19 +80.43 (+0.16%)
Ocumension Therapeutics (1477.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 11:41AM HKT. Market open.
| Previous close | 6.000 |
| Open | 6.000 |
| Bid | 6.180 x N/A |
| Ask | 6.190 x N/A |
| Day's range | 6.000 - 6.240 |
| 52-week range | 4.510 - 10.400 |
| Volume | |
| Avg. volume | 580,932 |
| Market cap | 4.287B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.640 |
| Earnings date | 21 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.59 |
PR NewswireOcuMension (01477.HK) Invests Over RMB 123.8 Million in Research, Technology and Self-development Progress in Tandem, Main Product Sales Show Comprehensive Growth
On the evening of March 21st, OcuMension Therapeutics (Shanghai) Co., Ltd. (01477.HK, hereinafter referred to as "OcuMension" or the "Company") disclosed its 2023 annual performance report. The company achieved a total operating income of RMB 246.4 million for the full year, a year-on-year increase of 55.0%; with a comprehensive gross profit of RMB 144.4 million, representing a year-on-year increase of 40.3%. During the reporting period, the company's major operating indicators performed well, b
© 2024 Yahoo. All rights reserved.